ECSP003805A - 4-PIRIDINIL-N-ACIL-L-FENILALANINAS - Google Patents
4-PIRIDINIL-N-ACIL-L-FENILALANINASInfo
- Publication number
- ECSP003805A ECSP003805A ECSP003805A ECSP003805A EC SP003805 A ECSP003805 A EC SP003805A EC SP003805 A ECSP003805 A EC SP003805A EC SP003805 A ECSP003805 A EC SP003805A
- Authority
- EC
- Ecuador
- Prior art keywords
- fenilalaninas
- piridinil
- acil
- vcam
- vla
- Prior art date
Links
- 108010008212 Integrin alpha4beta1 Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 abstract 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describen compuestos de la fórmula I, en los que de R1 a R7 tienen las definiciones descritas en las especificación; dichos compuestos son inhibidores de la unión entre las molécula VCAM-1 y las células de expresión del antígeno VLA-4 y, por consiguiente, son útiles para el tratamiento de enfermedades cuyos síntomas y/o lesiones pueden atribuirse a la unión de la molécula VCAM-1 con las células de expresión del VLA-4.Compounds of the formula I are described, in which R1 to R7 have the definitions described in the specifications; said compounds are inhibitors of the binding between the VCAM-1 molecule and the VLA-4 antigen expression cells and, therefore, are useful for the treatment of diseases whose symptoms and / or lesions can be attributed to the binding of the VCAM molecule -1 with VLA-4 expression cells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003805 ECSP003805A (en) | 2000-12-04 | 2000-12-04 | 4-PIRIDINIL-N-ACIL-L-FENILALANINAS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003805 ECSP003805A (en) | 2000-12-04 | 2000-12-04 | 4-PIRIDINIL-N-ACIL-L-FENILALANINAS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003805A true ECSP003805A (en) | 2001-07-27 |
Family
ID=42041361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003805 ECSP003805A (en) | 2000-12-04 | 2000-12-04 | 4-PIRIDINIL-N-ACIL-L-FENILALANINAS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003805A (en) |
-
2000
- 2000-12-04 EC ECSP003805 patent/ECSP003805A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26470A1 (en) | 4-PIRIDINYL - N - ACYL - PHENYLALANINS | |
| BR0016195A (en) | 4-pyrimidinyl-n-acyl-1-phenylalanines | |
| UY27169A1 (en) | DERIVATIVES OF THE ISOFTALIC ACID AS INHIBITORS OF METALPROTEINASES OF THE MATRIX | |
| NI200800169A (en) | USE OF BENZO-FUSED HETEROCYCLIC SULFAMID DERIVATIVES FOR THE TREATMENT OF PAIN | |
| ECSP088221A (en) | ALFA2C ADRENORECEPTORS AGONISTS | |
| CL2024003939A1 (en) | Compounds for treating spinocerebellar ataxia type 3 | |
| PY0224080A (en) | ALKYNES AS MATRIX METALLOPROTEINASE INHIBITORS | |
| CR6939A (en) | ZOPOLRESTAT MONOHIDRATE POLYMORPH | |
| AR069980A1 (en) | IMMUNOCONJUGADOS DIRECTED AGAINST CD 138 AND ITS USES | |
| AR054094A1 (en) | CANCER TREATMENTS | |
| MX9606744A (en) | HYDROXAMIC ACIDS REPLACED BY ARILIC SULFONAMIDE AS MATRIX METALOPROTEINASE INHIBITORS. | |
| CO6241131A2 (en) | VACCINE | |
| GT200900038A (en) | COMPOUNDS AND METHODS TO INHIBIT THE INTERACTION OF BCL PROTEINS WITH BINDING AGENTS | |
| NI200800175A (en) | USE OF BENZO-FUSED HETEROCYCLIC SULFAMID DERIVATIVES FOR THE TREATMENT OF SUBSTANCE ABUSE AND ADDICTION. | |
| HN1999000099A (en) | NON-PEPTIDILIC INHIBITORS OF THE UNION TO VELA-4 DEPENDENT CELLS USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES. | |
| BRPI0617167B8 (en) | sulfonylpyrroles as HDAC inhibitors, their use, pharmaceutical composition and combination | |
| AR065798A1 (en) | THERAPEUTIC USES OF 4- [2- (4-METHYLPHENYLSULPHANIL) PHENYL] PIPERIDINE | |
| CY1110130T1 (en) | MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A. | |
| AR021946A1 (en) | COMPOSITIONS CONTAINING PHENIRAMINE AND METHOD FOR THE TREATMENT OF ALLERGY RESPONSES | |
| BRPI0415203A (en) | restructured pentanols, a process for their production and use as anti-inflammatory agents | |
| CY1120368T1 (en) | Sequence of Specific Split MMR-14 | |
| PE20110677A1 (en) | N- (2-AMINOPHENIL) -4- [N- (PYRIDIN-3-IL) METOXYCARBONYLAMINE-METHYL] BENZAMIDE (MS-275) POLYMORPH B | |
| EA201270345A1 (en) | MODIFIED FRACTURE AGRINE, THE ABLE TO RESTORE MUSCLE POWER FOR USING AS A MEDICINE | |
| CR10690A (en) | NEW FLUORENE DERIVATIVES, COMPOSITIONS THAT CONTAIN THEM AND USE AS INHIBITORS OF CHAPERONA HSP90 PROTEIN | |
| ECSP003806A (en) | 4-PIRIDINIL-N-ACIL-L-FENILALANINAS |